Stay updated with breaking news from Rx Compound. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly has filed lawsuits in several states seeking to prevent unauthorized selling of products that claim to contain tirzepatide, the active ingredient in its blockbuster type 2 diabetes drug Mounjaro.
Eli Lilly on Tuesday said it was suing 10 US medical spas, wellness centers, and compounding pharmacies for selling products claiming to contain tirzepatide, the active ingredient in its diabetes drug Mounjaro.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo,
:max_bytes(150000):strip_icc()/GettyImages-1245722172-66c4cba55abf44e3be85b2a1340414c5.jpg)
Eli Lilly sued 10 medical spas, wellness centers, and compounding pharmacies across the U.S. for allegedly selling fraudulent products claiming to be its popular diabetes drug, Mounjaro.
Eli Lilly And Co (NYSE: LLY) has taken